Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Placebo-controlled trial of dronedarone for prevention of cardiovascular hospitalization or death in atrial fibrillation/flutter
2005-000715-98Phase 3Completed
- Sponsor
- Sanofi
- Start
- Apr 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in Atrial fibrillation (AFib) and atrial flutter (AFL) comparing Dronedarone arm with Placebo arm (2 arms). Started Apr 2005; status: completed.
02
Drugs
dronedarone
03
Conditions
Atrial fibrillation (AFib)atrial flutter (AFL)
Beyond the preview
Go deeper on 2005-000715-98.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-000715-98.